Riskpilot← Back to searchSign inGet full accessMyVision AB
ABActiveOrg 5565790655Sadelgatan 55Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19990 employees
Revenue 2024
—
EBITDA margin
—
+56% vs 2023
Equity ratio
26.5%
Financial strength
Net profit 2024
SEK -6K
+98% vs 2023
| Revenue | — | — |
| EBITDA | SEK -4K | +56% |
| Net profit | SEK -6K | +98% |
| Total assets | SEK 27K | -15% |
| Equity | SEK 7K | -44% |
| Employees | 0 | — |
Legal name
MyVision AB
Org number
5565790655
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18 november 1999
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av ledamoten Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolagets verksamhet är konsultarbeten, försäljning, utveckling av medicintekniska produkter inom hälso och sjukvård och därmed förenlig verksamhet.
Address
Sadelgatan 55
Phone
+4621300690
Email
leifaberg801@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | 104 | −23 | −15 | −9 | −4 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 104 | −23 | −15 | −9 | −4 |
| Net financials | −60 | −830 | — | −528 | −2 |
| Profit before tax | 56 | −392 | 3 | −273 | −6 |
| Tax | −12 | −8 | −1 | −0 | — |
| Net profit | 44 | −400 | 2 | −273 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 760 | 341 | 314 | 32 | 27 |
| Equity | 684 | 284 | 286 | 13 | 7 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 33 | 39 | 28 | 19 | 20 |
| Total debt | 33 | 39 | 28 | 19 | 20 |
EBITDA margin
-397500.0%
This company
15.8%
Market median
-2515923% vs market
20202024
Equity ratio
26.5%
This company
38.2%
Market median
-31% vs market
20202024
Return on equity
-87.0%
This company
18.4%
Market median
-573% vs market
20202024
Net profit margin
-627400.0%
This company
8.1%
Market median
-7745779% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.78×
This company
0.62×
Market median
-348% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MyVision AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Rune Åberg | Board of Directors | 0 companies |
| Lillwi Helen Persson | Deputy Board Member | 0 companies |